Suspected pyroglutamic acidosis in a complex patient: A case report
World Advances in Renal Medicine · 07.03.2026 · 2 · 84-86
DOI: 10.25259/warm_33_2025 ↗Kurz gefasst
Fallbericht in der Zeitschrift World Advances in Renal Medicine, online erschienen am 07.03.2026. Verfasst von Ammar Ali Al Ali und 1 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
We present the case of a 35-year-old female with multiple co-morbidities who developed unexplained high anion gap metabolic acidosis (HAGMA) despite marked improvement in sepsis parameters and other clinical conditions. Given the presence of known predisposing factors such as chronic therapeutic paracetamol (acetaminophen) use, chronic kidney disease, female gender, acute serious illness, undernutrition, and a dramatic improvement in acidosis following discontinuation of paracetamol without other overt explanations, we suspect acquired pyroglutamic acidosis (5-oxoproline acidosis) despite a lack of laboratory confirmation of 5-oxoproline. This case underlines the importance of recognizing this underdiagnosed cause of HAGMA.
Zitieren
APA
Ali, A. A. A., & AlShaaili, K. S. (2026). Suspected pyroglutamic acidosis in a complex patient: A case report. World Advances in Renal Medicine, 2, 84-86. https://doi.org/10.25259/warm_33_2025
Vancouver
Ali AAA, AlShaaili KS. Suspected pyroglutamic acidosis in a complex patient: A case report. World Advances in Renal Medicine. 2026;2:84-86. doi:10.25259/warm_33_2025
BibTeX
@article{Ali2026,
author = {Ali, Ammar Ali Al and AlShaaili, Khalfan Salim},
title = {Suspected pyroglutamic acidosis in a complex patient: A case report},
journal = {World Advances in Renal Medicine},
year = {2026},
volume = {2},
pages = {84--86},
doi = {10.25259/warm_33_2025}
}
EUVIMED